• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体因子H羧基末端结构揭示非典型溶血性尿毒症综合征的分子基础。

Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome.

作者信息

Jokiranta T Sakari, Jaakola Veli-Pekka, Lehtinen Markus J, Pärepalo Maria, Meri Seppo, Goldman Adrian

机构信息

Department of Bacteriology and Immunology, Haartman Institute, University of Helsinki, Helsinki, Finland.

出版信息

EMBO J. 2006 Apr 19;25(8):1784-94. doi: 10.1038/sj.emboj.7601052. Epub 2006 Apr 6.

DOI:10.1038/sj.emboj.7601052
PMID:16601698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1440827/
Abstract

Factor H (FH) is the key regulator of the alternative pathway of complement. The carboxyl-terminal domains 19-20 of FH interact with the major opsonin C3b, glycosaminoglycans, and endothelial cells. Mutations within this area are associated with atypical haemolytic uremic syndrome (aHUS), a disease characterized by damage to endothelial cells, erythrocytes, and kidney glomeruli. The structure of recombinant FH19-20, solved at 1.8 A by X-ray crystallography, reveals that the short consensus repeat domain 20 contains, unusually, a short alpha-helix, and a patch of basic residues at its base. Most aHUS-associated mutations either destabilize the structure or cluster in a unique region on the surface of FH20. This region is close to, but distinct from, the primary heparin-binding patch of basic residues. By mutating five residues in this region, we show that it is involved, not in heparin, but in C3b binding. Therefore, the majority of the aHUS-associated mutations on the surface of FH19-20 interfere with the interaction between FH and C3b. This obviously leads to impaired control of complement attack on plasma-exposed cell surfaces in aHUS.

摘要

补体因子H(FH)是补体替代途径的关键调节因子。FH的羧基末端结构域19-20与主要调理素C3b、糖胺聚糖和内皮细胞相互作用。该区域内的突变与非典型溶血性尿毒症综合征(aHUS)相关,这是一种以内皮细胞、红细胞和肾小球受损为特征的疾病。通过X射线晶体学在1.8埃分辨率下解析的重组FH19-20的结构显示,短共有重复序列结构域20异常地包含一个短α螺旋及其底部的一片碱性残基。大多数与aHUS相关的突变要么使结构不稳定,要么聚集在FH20表面的一个独特区域。该区域靠近但不同于主要的碱性残基肝素结合区。通过在该区域突变五个残基,我们表明它参与的不是肝素结合,而是C3b结合。因此,FH19-20表面上大多数与aHUS相关的突变会干扰FH与C3b之间的相互作用。这显然导致aHUS中对血浆暴露细胞表面的补体攻击控制受损。

相似文献

1
Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome.补体因子H羧基末端结构揭示非典型溶血性尿毒症综合征的分子基础。
EMBO J. 2006 Apr 19;25(8):1784-94. doi: 10.1038/sj.emboj.7601052. Epub 2006 Apr 6.
2
Both domain 19 and domain 20 of factor H are involved in binding to complement C3b and C3d.因子 H 的结构域 19 和结构域 20 都参与与补体 C3b 和 C3d 的结合。
Mol Immunol. 2010 May;47(9):1686-91. doi: 10.1016/j.molimm.2010.03.007. Epub 2010 Apr 7.
3
Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome.在非典型溶血性尿毒症综合征中,补体因子H的突变通过三种机制损害对表面结合C3b的调节。
J Biol Chem. 2009 Jun 5;284(23):15650-8. doi: 10.1074/jbc.M900814200. Epub 2009 Apr 7.
4
Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome.补体攻击导致内皮细胞和血小板上唾液酸识别紊乱,引起非典型溶血尿毒综合征。
Blood. 2016 Jun 2;127(22):2701-10. doi: 10.1182/blood-2015-11-680009. Epub 2016 Mar 22.
5
The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.在非典型溶血性尿毒症综合征中,补体因子H与细胞上的生理性多阴离子和C3b复合物的结合受损。
J Immunol. 2009 Jun 1;182(11):7009-18. doi: 10.4049/jimmunol.0804031.
6
Crystallographic determination of the disease-associated T1184R variant of complement regulator factor H.补体调节因子H疾病相关T1184R变体的晶体学测定
Acta Crystallogr D Biol Crystallogr. 2011 Jul;67(Pt 7):593-600. doi: 10.1107/S0907444911015423. Epub 2011 Jun 11.
7
Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site.人类补体因子H C端结构域的分子建模:溶血尿毒综合征与预测的肝素结合位点之间的相关性
J Mol Biol. 2002 Feb 15;316(2):217-24. doi: 10.1006/jmbi.2001.5337.
8
Structural and functional characterization of the product of disease-related factor H gene conversion.疾病相关因子 H 基因转换产物的结构与功能特征分析。
Biochemistry. 2012 Mar 6;51(9):1874-84. doi: 10.1021/bi201689j. Epub 2012 Feb 22.
9
Recognition of malondialdehyde-modified proteins by the C terminus of complement factor H is mediated via the polyanion binding site and impaired by mutations found in atypical hemolytic uremic syndrome.补体因子 H C 末端通过多阴离子结合位点识别丙二醛修饰的蛋白质,并被异常型溶血尿毒症综合征中发现的突变所破坏。
J Biol Chem. 2014 Feb 14;289(7):4295-306. doi: 10.1074/jbc.M113.527416. Epub 2013 Dec 16.
10
Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions.补体因子H与非典型溶血尿毒综合征:C末端突变导致结构改变及识别功能缺陷。
J Am Soc Nephrol. 2006 Jan;17(1):170-7. doi: 10.1681/ASN.2005080868. Epub 2005 Dec 7.

引用本文的文献

1
Complement therapeutic Factor H-IgG proteins as pre-exposure prophylaxes against Lyme borreliae infections.补体治疗性因子H-IgG蛋白作为莱姆疏螺旋体感染的暴露前预防措施。
bioRxiv. 2024 Sep 26:2024.09.26.615144. doi: 10.1101/2024.09.26.615144.
2
An optimized Factor H-Fc fusion protein against multidrug-resistant .一种针对多重耐药性的优化因子 H-Fc 融合蛋白。
Front Immunol. 2022 Aug 30;13:975676. doi: 10.3389/fimmu.2022.975676. eCollection 2022.
3
Beyond Panel-Based Testing: Exome Analysis Increases Sensitivity for Diagnosis of Genetic Kidney Disease.超越基于面板的检测:外显子组分析提高了遗传肾脏疾病诊断的灵敏度。
Kidney360. 2020 May 13;1(8):772-780. doi: 10.34067/KID.0001342020. eCollection 2020 Aug 27.
4
Mechanism of Borrelia immune evasion by FhbA-related proteins.弗氏柠檬酸杆菌相关蛋白的免疫逃避机制。
PLoS Pathog. 2022 Mar 18;18(3):e1010338. doi: 10.1371/journal.ppat.1010338. eCollection 2022 Mar.
5
Development of Complement Factor H-Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant .在烟草植物中基于补体因子 H 的免疫治疗分子的开发用于对抗多药耐药性。
Front Immunol. 2020 Oct 26;11:583305. doi: 10.3389/fimmu.2020.583305. eCollection 2020.
6
The solution structure of the complement deregulator FHR5 reveals a compact dimer and provides new insights into CFHR5 nephropathy.补体失调控因子 FHR5 的溶液结构揭示了一个紧凑的二聚体,并为 CFHR5 肾病提供了新的见解。
J Biol Chem. 2020 Nov 27;295(48):16342-16358. doi: 10.1074/jbc.RA120.015132. Epub 2020 Sep 14.
7
Characterization of Binding Properties of Individual Functional Sites of Human Complement Factor H.鉴定人补体因子 H 各功能位点的结合特性。
Front Immunol. 2020 Aug 4;11:1728. doi: 10.3389/fimmu.2020.01728. eCollection 2020.
8
Neonatal thrombotic microangiopathy secondary to factor I variant with Hirschsprung disease.继发于伴有先天性巨结肠的Ⅰ因子变异的新生儿血栓性微血管病
J Nephrol. 2021 Feb;34(1):241-245. doi: 10.1007/s40620-020-00766-5. Epub 2020 Jun 8.
9
The Human Platelet as an Innate Immune Cell: Interactions Between Activated Platelets and the Complement System.人类血小板作为先天免疫细胞:活化血小板与补体系统的相互作用。
Front Immunol. 2019 Jul 10;10:1590. doi: 10.3389/fimmu.2019.01590. eCollection 2019.
10
Two distinct conformations of factor H regulate discrete complement-binding functions in the fluid phase and at cell surfaces.两种不同构象的因子 H 调节液相和细胞表面上的离散补体结合功能。
J Biol Chem. 2018 Nov 2;293(44):17166-17187. doi: 10.1074/jbc.RA118.004767. Epub 2018 Sep 14.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.补体因子H与内皮细胞的结合是由羧基末端糖胺聚糖结合位点介导的。
Am J Pathol. 2005 Oct;167(4):1173-81. doi: 10.1016/S0002-9440(10)61205-9.
3
Structures of complement component C3 provide insights into the function and evolution of immunity.补体成分C3的结构为免疫功能和进化提供了见解。
Nature. 2005 Sep 22;437(7058):505-11. doi: 10.1038/nature04005.
4
Comparison of surface recognition and C3b binding properties of mouse and human complement factor H.小鼠和人补体因子H的表面识别及C3b结合特性比较
Mol Immunol. 2006 Mar;43(7):972-9. doi: 10.1016/j.molimm.2005.05.011. Epub 2005 Jul 14.
5
Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome.补体因子I的突变易导致非典型溶血性尿毒症综合征的发生。
J Am Soc Nephrol. 2005 Jul;16(7):2150-5. doi: 10.1681/ASN.2005010103. Epub 2005 May 25.
6
Complement factor H polymorphism and age-related macular degeneration.补体因子H基因多态性与年龄相关性黄斑变性
Science. 2005 Apr 15;308(5720):421-4. doi: 10.1126/science.1110189. Epub 2005 Mar 10.
7
Interdomain contact regions and angles between adjacent short consensus repeat domains.相邻短共有重复序列结构域之间的结构域间接触区域和角度。
J Mol Biol. 2004 Dec 10;344(5):1385-96. doi: 10.1016/j.jmb.2004.10.017.
8
Refinement of macromolecular structures by the maximum-likelihood method.用最大似然法优化大分子结构。
Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55. doi: 10.1107/S0907444996012255.
9
Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation.痘苗补体蛋白与肝素复合物的结构及其对补体调节的潜在影响。
Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):8924-9. doi: 10.1073/pnas.0400744101. Epub 2004 Jun 3.
10
The human complement factor H: functional roles, genetic variations and disease associations.人类补体因子H:功能作用、基因变异与疾病关联
Mol Immunol. 2004 Jun;41(4):355-67. doi: 10.1016/j.molimm.2004.02.005.